IgA Nephropathy

IgA Nephropathy is a topic covered in the 5-Minute Clinical Consult.

To view the entire topic, please or purchase a subscription.

Medicine Central™ is a quick-consult mobile and web resource that includes diagnosis, treatment, medications, and follow-up information on over 700 diseases and disorders, providing fast answers—anytime, anywhere. Explore these free sample topics:

Medicine Central

-- The first section of this topic is shown below --



  • Most common form of glomerulonephritis in the world
  • Renal parenchymal damage and dysfunction defined by deposition of IgA in glomerular mesangium
  • Significant contributor to the incidence of end-stage renal disease (ESRD) in parts of Asia


In patients who undergo renal biopsy, the following incidence was reported: 30–40% in Asia, 15–20% in Europe, and 5–10% in North America

  • Highest prevalence in Pacific Rim, particularly Japan and Korea
  • More common in Asians, whites, and American Indians versus blacks in the United States and Africa

Etiology and Pathophysiology

  • Familial forms of IgA nephropathy (IgAN) exist with no specific gene identified.
  • IgA1 molecules deposit within the mesangium leading to an inflammatory reaction with eventual fibrosis and scarring of the nephron.

Risk Factors

  • Liver disease: Impaired removal of IgA by Kupffer cells in the liver predisposes individuals to IgA deposition in the kidney.
  • Celiac disease: Ingestion of gliadin results in the formation of IgA antigliadin antibodies and deposition of immune complexes in the kidney.

Commonly Associated Conditions

  • Henoch-Schönlein purpura
  • Hepatic failure
  • Celiac disease
  • Rheumatoid arthritis
  • Ankylosing spondylitis
  • Reiter syndrome
  • HIV
  • CMV

-- To view the remaining sections of this topic, please or purchase a subscription --